Leerink Partners Assumes MindMed (MNMD) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts MNMD Hot Sheet
Price: $15.02 --0%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 14
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 14
Join SI Premium – FREE
Leerink Partners analyst Marc Goodman assumes coverage on MindMed (NASDAQ: MNMD) with a Outperform rating and a price target of $20.00.
For an analyst ratings summary and ratings history on MindMed click here. For more ratings news on MindMed click here.
Shares of MindMed closed at $5.41 yesterday.
You May Also Be Interested In
- Lucid Capital Markets Starts Hyperfine Inc. (HYPR) at Buy
- Truist Securities Starts Evergy (EVRG) at Buy
- Piper Sandler Assumes Delek US (DK) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
